Clinical Trial Update: To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating safety, tolerability, and pharmacodynamics of GSK2890457 in healthy volunteers and individuals with obesity-related conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GSK2890457 (GSK2890457)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2017-10-23